Liquidia, An IBD 50 Stock, Tops Sales Views Amid United Therapeutics Rivalry

Reported by Yahoo Finance · Published 12 Aug 2026, 8:30 PM MYT (1 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Consumer prices rose 0.1% in July, as expected, putting the annual rate at 3.4% 1 hr ago US inflation eases as food costs cool 1 hr ago Australia to make tech companies pay more outlets for content under reworked media law 1 hr ago U.S. CPI inflation slows to 3.4% as expected, bitcoin holds near $64,000 1 hr ago Stocks Futures Perk Up After July Inflation Report 1 hr ago US inflation cooled again but still outpaced paychecks in July 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Liquidia, An IBD 50 Stock, Tops Sales Views Amid United Therapeutics Rivalry

Summary

More in Markets

Stocks Futures Perk Up After July Inflation Report

US inflation cooled again but still outpaced paychecks in July

U.S. CPI rose 0.1% in July 2026, annual inflation at 3.4%

CoreWeave’s stock is rocketing after earnings lead to praise from bulls and bears alike

Here's the biggest risk to America's data center building boom

Accel deepens Europe presence with $800M allocation